STIPULATION OF VOLUNTARY DISMISSAL WITHOUT PREJUDICE PURSUANT TO FED. R. CIV. P. 41(a)(1)

JAMES WARE, Judge.

WHEREAS, on October 27, 2010, the Court appointed George Berneshawi and Luciano Garzelli to serve as Lead Plaintiffs and approved their selection of Lead Counsel in this federal class action brought on behalf of purchasers of the common stock of SciClone Pharmaceuticals, Inc. ("SciClone"), seeking to pursue remedies under the Securities Exchange Act of 1934 against defendants SciClone Pharmaceuticals, Inc., Friedhelm Blobel, and Gary S. Titus (collectively, "Defendants");

WHEREAS, the Court established a schedule for Lead Plaintiffs to file an Amended Consolidated Complaint on or before November 29, 2010, and for briefing related to anticipated motion(s) to dismiss, Rec. Doc. No. 25;

WHEREAS, Lead Counsel for Lead Plaintiffs and counsel for Defendants have conferred regarding the allegations in the action, and the schedule ordered by the Court;

WHEREAS, no class has been certified in this action pursuant to Fed. R. Civ. P. 23; and

WHEREAS, no consideration has been or will be exchanged between the parties in connection with the dismissal of the action,

IT IS HEREBY STIPULATED by and between the undersigned counsel for all parties who have appeared in this action, that pursuant to Fed. R. Civ. P. 41(a)(1), this case be voluntarily dismissed without prejudice and without cost; and all parties will bear their own costs. The Clerk shall close this file.

ATTESTATION PURSUANT TO GENERAL ORDER 45

I, Kim E. Miller, attest that concurrence in the filing of this document was obtained from the other signatories noted above.

I declare under penalty of perjury under the laws of the United States of America that the foregoing is true and correct. Dated this 24th day of November 2010, in New York, New York.